Orthopediatrics (KIDS) 10% Owner David Pelizzon Sells Shares

What Happened David R. Pelizzon, reported as a 10% owner via Squadron Capital LLC, sold a total of 336,831 shares of Orthopediatrics (KIDS) in open-market/private sales on August 28 and September 1, 2026. The filing shows sales of 326,700 shares on 2026-08-28 for $23.04 (weighted average) totaling $7,527,168, and 10,131 shares on 2026-09-01 for $23.10 (weighted average) totaling $234,026 — combined proceeds of about $7.76 million. Sales were executed in multiple transactions (see footnotes for price ranges).

Key Details

• Transaction dates and prices:
  • 2026-08-28: 326,700 shares sold, weighted avg $23.04; reported price range $23.00–$23.82. (Footnotes F2)
  • 2026-09-01: 10,131 shares sold, weighted avg $23.10; reported price range $23.00–$23.58. (Footnote F4)
• Total shares sold: 336,831; total proceeds ≈ $7,761,194.
• Holdings after transaction: the filing does not list a total “shares owned after” amount; it notes holdings include 17,959 restricted shares (Footnote F5).
• Reporting/ownership notes:
  • The sales were undertaken by Squadron Capital LLC to provide additional capital for its other portfolio businesses (F1).
  • Pelizzon is President and a Managing Committee member of Squadron and may be deemed to beneficially own the Squadron-held shares, but he expressly disclaims beneficial ownership except to the extent of his pecuniary interest (F3).
• Filing timeliness: Form 4 was filed on 2026-09-01 covering the 8/28 and 9/1 transactions; the report appears to have been filed within the normal Section 16 timing window.

Context

• These are outright sales (transaction code S). Sales by a 10% owner or by an affiliated investment vehicle are often institutional liquidity moves rather than signals about company fundamentals. Footnotes indicate the trades funded other portfolio businesses and were executed in multiple tranches at slightly varying prices.